|
US6268392B1
(en)
*
|
1994-09-13 |
2001-07-31 |
G. D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
|
|
CN1217656C
(zh)
*
|
1995-11-02 |
2005-09-07 |
沃尼尔·朗伯公司 |
用于调节脂浓度的方法和药物组合物
|
|
EP1514543A1
(en)
*
|
1997-08-29 |
2005-03-16 |
Pfizer Inc. |
Combination therapy comprising atorvastatin and an antihypertensive agent
|
|
GT199800126A
(es)
*
|
1997-08-29 |
2000-01-29 |
|
Terapia de combinacion.
|
|
GT199800127A
(es)
|
1997-08-29 |
2000-02-01 |
|
Combinaciones terapeuticas.
|
|
KR20010041916A
(ko)
*
|
1998-03-17 |
2001-05-25 |
로즈 암스트롱, 크리스틴 에이. 트러트웨인 |
스타틴-매트릭스 메탈로프로테이나제 저해제 복합제제
|
|
US6221897B1
(en)
*
|
1998-06-10 |
2001-04-24 |
Aventis Pharma Deutschland Gmbh |
Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
|
|
CZ20011035A3
(cs)
*
|
1998-09-30 |
2001-10-17 |
Warner-Lambert Company |
Léčivo pro prevenci nebo oddálení revaskularizace pomocí katetru u pacientů postiľených chorobou koronární artérie
|
|
CO5140104A1
(es)
*
|
1999-02-16 |
2002-03-22 |
Novartis Ag |
Derivados de mevinolina y preparacion farmaceuticas que los contienen
|
|
US20010006656A1
(en)
*
|
1999-02-17 |
2001-07-05 |
University Of Washington |
Methods and compositions for inhibiting inflammation associated with pulmonary disease
|
|
AU7717500A
(en)
*
|
1999-09-30 |
2001-04-30 |
Merck & Co., Inc. |
Anti-hypercholesterolemic drug combination
|
|
EP1092432A1
(fr)
|
1999-10-15 |
2001-04-18 |
Societe De Conseils De Recherches Et D'applications Scientifiques S.A. (S.C.R.A.S.) |
Composes anti-ischemiques
|
|
KR20020050257A
(ko)
*
|
1999-11-05 |
2002-06-26 |
로즈 암스트롱, 크리스틴 에이. 트러트웨인 |
Ａｃａｔ 저해제에 의한 플라크 파열의 방지
|
|
WO2002020009A1
(en)
*
|
2000-09-01 |
2002-03-14 |
Sankyo Company, Limited |
Medicinal compositions
|
|
MXPA03003022A
(es)
|
2000-10-11 |
2003-07-14 |
Esperion Therapeutics Inc |
Compuestos de sulfuro y disulfuro y composiciones para el control del colesterol y usos relacionados.
|
|
US7304093B2
(en)
*
|
2000-10-11 |
2007-12-04 |
Esperion Therapeutics, Inc. |
Ketone compounds and compositions for cholesterol management and related uses
|
|
CA2425678A1
(en)
|
2000-10-11 |
2002-04-18 |
Jean-Louis H. Dasseux |
Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
|
|
JP2004529069A
(ja)
|
2000-10-11 |
2004-09-24 |
エスペリオン セラピューティクス，インコーポレイテッド |
コレステロール管理用のエーテル化合物及び組成物ならびに関連する使用
|
|
EP1326822A2
(en)
|
2000-10-11 |
2003-07-16 |
Esperion Therapeutics Inc. |
Ketone compounds and compositions for cholesterol management and related uses
|
|
US20040122091A1
(en)
*
|
2000-10-11 |
2004-06-24 |
Esperion Therapeutics, Inc. |
Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
|
|
CA2369967A1
(en)
*
|
2001-02-12 |
2002-08-12 |
Joseph Anthony Cornicelli |
Methods of treating nuclear factor-kappa b mediated diseases and disorders
|
|
PE20030324A1
(es)
*
|
2001-07-31 |
2003-04-03 |
Warner Lambert Co |
Composiciones farmaceuticas de amlodipina y atorvastatina
|
|
US20040204502A1
(en)
*
|
2001-10-11 |
2004-10-14 |
Dasseux Jean-Louis Henri |
Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
|
|
US20040192771A1
(en)
*
|
2001-10-11 |
2004-09-30 |
Dasseux Jean-Louis Henri |
Ether compounds and compositions for cholesterol management and related uses
|
|
US20050020694A1
(en)
*
|
2001-10-11 |
2005-01-27 |
Dasseux Jean-Louis Henri |
Sulfide and disulfide compounds and compositions for cholesterol management and related uses
|
|
EP1485077A4
(en)
*
|
2002-03-12 |
2007-07-18 |
Merck & Co Inc |
DRUGS COMBINATION THERAPY
|
|
CA2480410A1
(en)
*
|
2002-04-10 |
2003-10-23 |
Esperion Therapeutics, Inc. |
Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
|
|
JP4187141B2
(ja)
*
|
2002-04-12 |
2008-11-26 |
興和株式会社 |
新規なトロンボモジュリン発現促進剤
|
|
US7119221B2
(en)
|
2003-01-23 |
2006-10-10 |
Esperion Therapeutics, Inc. |
Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
|
|
RU2358734C2
(ru)
|
2003-08-29 |
2009-06-20 |
Кова Ко., Лтд. |
Способ стабилизации бляшки с высоким содержанием липидов и способ профилактики ее разрушения
|
|
EP1688140A1
(en)
*
|
2003-11-17 |
2006-08-09 |
Toyo Shinyaku Co., Ltd. |
Lipometabolism improver containing pine bark extract
|
|
AU2003304703A1
(en)
*
|
2003-12-24 |
2005-08-03 |
Esperion Therapeutics, Inc. |
Ketone compounds and compositions for cholesterol management and related uses
|
|
WO2005102348A1
(en)
*
|
2004-04-19 |
2005-11-03 |
Loma Linda University |
Composition and method of decreasing renal ischemic damage
|
|
TW200605890A
(en)
*
|
2004-07-28 |
2006-02-16 |
Sankyo Co |
Pharmaceutical compositions for inhibiting arteriosclerosis
|
|
KR101021828B1
(ko)
*
|
2004-10-27 |
2011-03-17 |
다이이찌 산쿄 가부시키가이샤 |
2 이상의 치환기를 갖는 벤젠 화합물
|
|
TW200619204A
(en)
*
|
2004-12-10 |
2006-06-16 |
Kowa Co |
Method for reduction, stabilization and prevention of rupture of lipid rich plaque
|
|
KR101329112B1
(ko)
*
|
2005-11-08 |
2013-11-14 |
랜박시 래보러터리스 리미티드 |
(3ｒ,5ｒ)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법
|
|
RU2308947C1
(ru)
*
|
2006-02-26 |
2007-10-27 |
Новосибирский институт органической химии им. Н.Н. Ворожцова СО РАН (НИОХ СО РАН) |
Лекарственное средство с гиполипидемическим эффектом "симваглизин"
|
|
PL2018153T3
(pl)
|
2006-04-26 |
2012-09-28 |
Rosemont Pharmaceuticals Ltd |
Ciekłe kompozycje doustne
|
|
US20130254787A1
(en)
|
2006-05-02 |
2013-09-26 |
Invidi Technologies Corporation |
Method and apparatus to perform real-time audience estimation and commercial selection suitable for targeted advertising
|
|
US20070269503A1
(en)
*
|
2006-05-16 |
2007-11-22 |
James Walter Burgess |
Combinations of HMG CoA reductase inhibitors and negatively charged phospholipids and uses thereof
|
|
US8314080B2
(en)
|
2010-04-06 |
2012-11-20 |
Kuwait University |
Method of treating type I diabetes
|
|
CN102424663B
(zh)
*
|
2010-12-03 |
2013-08-14 |
天津滨江药物研发有限公司 |
一种阿托伐他汀氨基酸盐及其制备方法
|
|
US8586527B2
(en)
*
|
2011-10-20 |
2013-11-19 |
Jaipal Singh |
Cerivastatin to treat pulmonary disorders
|
|
SG11201401849QA
(en)
|
2011-10-28 |
2014-05-29 |
Lumena Pharmaceuticals Inc |
Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
|
|
SG10201406155QA
(en)
|
2011-10-28 |
2014-11-27 |
Lumena Pharmaceuticals Inc |
Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases
|
|
CN103304496A
(zh)
*
|
2012-03-08 |
2013-09-18 |
南京工业大学 |
一种合成申嗪霉素方法
|
|
US10047034B2
(en)
|
2012-05-16 |
2018-08-14 |
Prairie Berry Europe Gmbh |
Polyhydroxylated pentacyclic triterpene acids as HMG-COA reductase inhibitors
|
|
KR102370582B1
(ko)
|
2015-03-13 |
2022-03-04 |
에스페리온 테라피유틱스 인코포레이티드 |
Ｅｔｃ1002 및 에제티미브를 포함하는 고정 용량 조합 및 제형 및 심혈관 질환의 치료 또는 이의 위험의 감소 방법
|
|
MA41793A
(fr)
|
2015-03-16 |
2018-01-23 |
Esperion Therapeutics Inc |
Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
|
|
JP2022537049A
(ja)
|
2019-06-21 |
2022-08-23 |
エスペリオン・セラピューティクス・インコーポレイテッド |
ベンペド酸の製造方法及びその組成物
|